Brief Motivational Therapy Versus Usual Care for Alcohol Use Disorders in Primary Care.

Not Applicable

• Conditions: Alcohol Use Disorder
• Interventions: Behavioral: Brief motivational treatment; Behavioral: Enhanced Usual Care

• Registration Number: NCT04345302
• Lead Sponsor: Nicolás Barticevic

Brief Summary

Harmful alcohol use is a leading cause of global disability and death. However increased detection and brief intervention capacity of more severe alcohol use disorders (AUD) has not been accompanied by increased availability of treatment services. Incorporating treatment for such disorders into primary care (PC) is of paramount importance for improving access and health outcomes. This study aims to estimate the effectiveness of a Brief Motivational Treatment (BMT) applied in primary care for treatment of these disorders.

This trial aims to test the superiority of BMT over enhanced usual care with a reasonable margin, over which the BMT could be further considered for incorporation into PC in Chile. Its pragmatic approach ultimately aims to inform policymakers about the benefit of including a brief psychosocial treatment into PC.

Detailed Description

This exploratory trial aims to estimate the effectiveness of a BMT for AUD provided in PC. The underlying question is whether Chilean PC should incorporate this treatment among its regular programs based on its effectiveness.

To answer this question, a randomised comparison between the manualized BMT and EUC will be undertaken. The main hypothesis is a superiority one:

• Participants under BMT will perform better than EUC in the reduction of alcohol consumption.

Also, there are ancillary questions that deserve special attention. The following hypotheses will help with the explanation of the results:

* Active BMT components (i.e., the working alliance and fidelity to the MI strategies) mediate the effect.

* Participant´s AUD severity mediates the effect.

* Participants under BMT will receive a higher amount of additional care (physician consultations, social worker consultations, participation in alcoholic anonymous, and others).

Study Timeline

• Study First Submitted: 2020-04-08
• Study First Submitted QC: 2020-04-10
• Study First Posted: 2020-04-14
• Study Start: 2021-11-01
• Status Verified: 2021-12
• Last Update Submitted: 2021-12-20
• Last Update Posted: 2022-01-11
• Primary Completion: 2022-11
• Study Completion: 2022-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 182

Inclusion Criteria

• Clinical diagnosis of alcohol use disorder according to the DSM-V (American Psychiatric Association, 2013
• Must fulfill criteria for alcohol use disorder and criteria for harmful alcohol use during the last month, i.e., five or more heavy drinking occasions in the last month (5 or more drinks in men, 4 or more in women), or an average use of 14 or more drinks a week in men, and 7 or more in women
• Also, alcohol use should be the main problem motivating participants to seek treatment.

Exclusion Criteria

• Clients under 20 years old
• Clients in whom alcohol use is not the main problem
• Clients who leave the area or are unable for follow-up contact
• Clients with severe mental comorbidity
• Clients with severe cognitive impairment, illiteracy, or unable to follow treatment in Spanish.
• Clients who are concurrently receiving or planning to receive other psychosocial treatment for alcohol use disorder other than usual care, i.e., formal professional treatment outside of primary care. Participation in community services and Alcoholics Anonymous is permissible.
• Clients who have previously participated in the study, or whose family members are or have been participants.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Brief motivational treatment	Brief motivational treatment	Participants in the intervention group will receive the Brief Motivational Treatment, which is a primary care-adaptation of the Motivational Enhancement Therapy as manualized in the Project MATCH \[19\]. This treatment consists of four 45-minute sessions, provided by a psychologist at weeks one, two, six, and twelve. The first three sessions, occurring during the first six weeks, are more active regarding the behavioural change, while the last session functions as closure and review of the process. If a participant asks for more support, they will be able to attend up to two extra sessions before the last one. The main adaptations are: * The translation into Chilean Spanish. * Update of Motivational Interview concepts. * Companion training material that includes a demonstrative video and practical exercises. * An adapted personalized feedback procedure. * Information on additional resources available in the primary care centre and the community.
Enhanced usual care	Enhanced Usual Care	All participants will receive an educational brochure on alcohol use disorder, with self-help materials and guides on how to get additional support. The physicians within the PC centre will also receive information on how to diagnose alcohol use disorders, prescription guides for the medications that are available for treating these disorders in the PC centre (mainly Disulfiram and any other if available), and directions on when and where to refer clients for treatment.
Brief motivational treatment	Enhanced Usual Care	Participants in the intervention group will receive the Brief Motivational Treatment, which is a primary care-adaptation of the Motivational Enhancement Therapy as manualized in the Project MATCH \[19\]. This treatment consists of four 45-minute sessions, provided by a psychologist at weeks one, two, six, and twelve. The first three sessions, occurring during the first six weeks, are more active regarding the behavioural change, while the last session functions as closure and review of the process. If a participant asks for more support, they will be able to attend up to two extra sessions before the last one. The main adaptations are: * The translation into Chilean Spanish. * Update of Motivational Interview concepts. * Companion training material that includes a demonstrative video and practical exercises. * An adapted personalized feedback procedure. * Information on additional resources available in the primary care centre and the community.

Primary Outcome Measures

Name	Time	Method
Change in the Drinks per Drinking Day (DDD)	Baseline and six-months follow-up	The change from baseline in the DDD during the last 90 days. The DDD will be aggregated using means.

Secondary Outcome Measures

Name	Time	Method
Change in the alcohol use pattern	Baseline and six-months follow-up	The number of participants with a low-risk alcohol use pattern estimated by the number of days of consumption, of abstinence, and intoxication during the last 90 days, aggregated using the proportion of participants per group.
Change in the negative consequences of alcohol use	Baseline and six-months follow-up	The change from baseline in the negative secondary consequences of alcohol consumption will be measured using the Drinker Inventory of Consequences (DrInC-2R) questionnaire, and will be aggregated using means. The DrInC-2R has a score range from 0 to 150, with higher scores indicating higher consequences.
Change in the severity of the dependency	Baseline and six-months follow-up	The change from baseline in the severity of the alcohol use disorder using the Substance Dependence Severity Scale. Means will be used to aggregate participants' DAYS, SEV, and WORST SEV scores for alcohol.; The DAYS score varies on an 8-point scale ranging from 0 (symptom did not occur) to 7 (symptom occurred every day of past 30). The SEV and WORST SEV severity variables are scored on a 6-point scale ranging from 0 (absent) to 5 (extreme), with a score of '2' indicating that the diagnostic criterion has been met. Lower scales scores represent less severe dependence, and higher scale scores reflect more severe dependence.
Abstinence days	At six-months follow-up	The most extended period of abstinence since enrolment. The number of abstinence days of each participant will be aggregated using means.
Change in the motivation for change	Baseline and six-months follow-up	The change from baseline in the motivational stage measured with the Stages of Change Readiness and Treatment Eagerness Scale-Drug (SOCRATES). The proportion of participants that improve their motivational stage will be used to aggregate the measurement in each group. The SOCRATES scores range within three dimensions: Recognition (7 - 35), Ambivalence (4 - 20), and Taking Steps (8 - 40), with higher scores indicating higher involvement in the dimension.

Trial Locations

Locations (3)

CESFAM Juan Pablo II; 🇨🇱 Santiago, Chile

CESFAM San Alberto Hurtado; 🇨🇱 Santiago, Chile

CESFAM Madre Teresa de Calcuta; 🇨🇱 Santiago, Chile